Asset Details
Do you wish to reserve the book?
Preliminary autopsy findings from the Harvard Aging Brain Study
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Preliminary autopsy findings from the Harvard Aging Brain Study
Do you wish to request the book?
Preliminary autopsy findings from the Harvard Aging Brain Study
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Preliminary autopsy findings from the Harvard Aging Brain Study
2025
Overview
Background The Harvard Aging Brain Study (HABS) is a longitudinal observational study on the differences between “normal” aging and preclinical AD. Sixteen HABS participants have undergone brain donation. We evaluate to what extent PET biomarkers predict neuropathologic assessments. Method Neuropathologic assessments of amyloid‐β plaques (Thal phase/A score), tau neurofibrillary tangles (Braak NFT stage/B score) and neuritic plaques (CERAD NP score/C score) were compared with antemortem PET. For amyloid‐β PET (PiB), the frontal, lateral temporal, parietal, and retrosplenial cortices (FLR) distribution volume ratio (DVR) and spatial extent (EXT) were calculated. For tau PET (flortaucipir, FTP), the whole temporal, temporal allocortex (MTL), and temporal neocortex (NEO‐T) standardized uptake value ratios (SUVRs) were calculated, using bilateral and lateralized regions (left or right, whichever is greater). PET‐neuropathologic correlations were measured with Spearman's ρ. Result PiB FLR DVR and EXT correlate significantly with A (ρ=0.81, p = 0.00029 and ρ=0.73, p = 0.0020) and C score (ρ=0.73, p = 0.0019 and ρ=0.77, p = 0.00087). Two cases had unusually low FTP SUVRs and high B scores (Cases #14 and #16, Table 1). Initially no FTP SUVR correlated significantly with B score. After removing the aforementioned outliers, whole temporal and NEO‐T SUVR correlated significantly with B score (both ρ=0.76, p = 0.017, n = 9). After additionally removing an MTL‐sparing case (spared at the time of PET acquisition, Case #8), MTL SUVR correlated significantly with B score (ρ=0.78, p = 0.021, n = 8). Lateralizing SUVRs strengthened correlations with B score for whole temporal (ρ=0.86, p = 0.0031, n = 9) and MTL (ρ=0.87, p = 0.0054, n = 8). Conclusion Amyloid‐β PET metrics correlated with amyloid‐β plaque spatial distribution and density, while tau PET metrics correlated with tau NFT spatial distribution only after removing outliers. These outliers suggest that PET‐neuropathologic discrepancies arise with tau PET more so than amyloid‐β PET, and were driven by: primary age‐related tauopathy, Braak NFT stage III; amyloid‐β‐driven tau spread (“ca‐tau‐strophe”) between imaging and death; and variability and asymmetry in tau accumulation. In conclusion, individualized tau PET metrics that respect the heterogeneity in tauopathy may be better able to predict neuropathologic assessments.
